Advances in our understanding of the influence of gender on patient outcomes with peripheral arterial disease co-occurring with diabetes

References

• Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg. 1999;12(2):123–137.
   PubMedGoogle Scholar
• Murabito JM, Evans JC, Larson MG, et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med. 2003;163(16):1939–1942.
   PubMedGoogle Scholar
• Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381–386.
   PubMed Web of Science ®Google Scholar
• McDermott MM, Guralnik JM, Ferrucci L, et al. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation. 2008;117(19):2484–2491.
   PubMed Web of Science ®Google Scholar
• Fowkes FG, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992;135(4):331–340.
   PubMed Web of Science ®Google Scholar
• Murabito JM, D’Agostino RB, Silbershatz H, et al. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation. 1997;96(1):44–49.
   PubMed Web of Science ®Google Scholar
• Jude EB, Oyibo SO, Chalmers N, et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24(8):1433–1437.
   PubMed Web of Science ®Google Scholar
• Hernandez-Vila EA. Peripheral arterial disease in women: the effect of gender on diagnosis and treatment. Tex Heart Inst J. 2011;38(2):154–156.
   PubMed Web of Science ®Google Scholar
• Allison MA, Ho E, Denenberg JO, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32(4):328–333.
   PubMed Web of Science ®Google Scholar
• Nehler MR, Duval S, Diao L, et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014;60(3):686–695.e682.
   PubMed Web of Science ®Google Scholar
• Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995;91(5):1472–1479.
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Allison MA, Gomes AS, et al. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125(11):1449–1472.
   PubMed Web of Science ®Google Scholar
• Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71(3):510–515.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Higgins JA. Epidemiology of peripheral arterial disease in women. J Epidemiol. 2003;13(1):1–14.
   PubMed Web of Science ®Google Scholar
• McDermott MM, Fried L, Simonsick E, et al. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women’s health and aging study. Circulation. 2000;101(9):1007–1012.
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–e654.
   PubMed Web of Science ®Google Scholar
• Adler AI, Stevens RJ, Neil A, et al. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002;25(5):894–899.
   PubMed Web of Science ®Google Scholar
• Ness J, Aronow WS, Ahn C. Prevalence of coronary artery disease, ischemic stroke, and symptomatic peripheral arterial disease and of associated risk factors in older men and women with and without diabetes mellitus. Prev Cardiol. 2000;3(4):160–162.
   PubMedGoogle Scholar
• Melton LJ, Macken KM, Palumbo PJ, et al. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care. 1980;3(6):650–654.
   PubMed Web of Science ®Google Scholar
• Beks PJ, Mackaay AJ, de Neeling JN, et al. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia. 1995;38(1):86–96.
   PubMed Web of Science ®Google Scholar
• Walters DP, Gatling W, Mullee MA, et al. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med. 1992;9(8):710–715.
   PubMed Web of Science ®Google Scholar
• Elhadd T, Robb R, Jung RT, et al. Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Practical Diabetes International. 1999;16(6):63–166.
   Google Scholar
• Althouse AD, Abbott JD, Forker AD, et al. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the bypass angioplasty revascularization investigation in type 2 diabetes (BARI 2D) trial. Diabetes Care. 2014;37(5):1346–1352.
   PubMed Web of Science ®Google Scholar
• Aronow WS, Ahn C, Weiss MB, et al. Relation of increased hemoglobin A(1c) levels to severity of peripheral arterial disease in patients with diabetes mellitus. Am J Cardiol. 2007;99(10):1468–1469.
   PubMed Web of Science ®Google Scholar
• James RW, Boemi M, Sirolla C, et al. Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia. 1995;38(6):711–714.
   PubMed Web of Science ®Google Scholar
• Association AD. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–3341.
   PubMed Web of Science ®Google Scholar
• Murabito JM, Evans JC, Nieto K, et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143(6):961–965.
   PubMed Web of Science ®Google Scholar
• Bianchi C, Penno G, Pancani F, et al. Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes. Diabetes Res Clin Pract. 2007;78(2):246–253.
   PubMed Web of Science ®Google Scholar
• Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes–a review. Diabet Med. 2010;27(1):4–14.
   PubMed Web of Science ®Google Scholar
• Pitocco D, Tesauro M, Alessandro R, et al. Oxidative stress in diabetes: implications for vascular and other complications. Int J Mol Sci. 2013;14(11):21525–21550.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349–1354.
   PubMed Web of Science ®Google Scholar
• Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47(5):921–929.
   PubMed Web of Science ®Google Scholar
• Madonna R, De Caterina R. Cellular and molecular mechanisms of vascular injury in diabetes–part I: pathways of vascular disease in diabetes. Vascul Pharmacol. 2011;54(3–6):68–74.
   PubMed Web of Science ®Google Scholar
• Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama. 2002;287(19):2570–2581.
   PubMed Web of Science ®Google Scholar
• Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33(1):13–18.
   PubMed Web of Science ®Google Scholar
• Hale WE, Marks RG, May FE, et al. Epidemiology of intermittent claudication: evaluation of risk factors. Age Ageing. 1988;17(1):57–60.
   PubMed Web of Science ®Google Scholar
• Maynard C, Litwin PE, Martin JS, et al. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med. 1992;152(5):972–976.
   PubMedGoogle Scholar
• Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004;172(1):95–105.
   PubMed Web of Science ®Google Scholar
• Moussa ID, Jaff MR, Mehran R, et al. Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study. Catheter Cardiovasc Interv. 2009;73(6):719–724.
   PubMed Web of Science ®Google Scholar
• Teodorescu VJ, Vavra AK, Kibbe MR. Peripheral arterial disease in women. J Vasc Surg. 2013;57(4 Suppl):18S–26S.
   PubMed Web of Science ®Google Scholar
• Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med. 1998;158(6):617–621.
   PubMedGoogle Scholar
• Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 1995;214(3):847–855.
   PubMed Web of Science ®Google Scholar
• Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes. 1989;38(4):504–509.
   PubMed Web of Science ®Google Scholar
• Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension. 1997;29(3):691–699.
   PubMed Web of Science ®Google Scholar
• Eraso LH, Fukaya E, Mohler ER, et al. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol. 2014;21(6):704–711.
   PubMed Web of Science ®Google Scholar
• Lu JT, Creager MA. The relationship of cigarette smoking to peripheral arterial disease. Rev Cardiovasc Med. 2004;5(4):189–193.
   PubMedGoogle Scholar
• Gerhard M, Baum P, Raby KE. Peripheral arterial-vascular disease in women: prevalence, prognosis, and treatment. Cardiology. 1995;86(4):349–355.
   PubMed Web of Science ®Google Scholar
• Volpato S, Vigna GB, McDermott MM, et al. Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study). Am J Cardiol. 2010;105(12):1825–1830.
   PubMed Web of Science ®Google Scholar
• Forbang NI, Criqui MH, Allison MA, et al. Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg. 2016;63:453–458.
   PubMed Web of Science ®Google Scholar
• Tkác I, Molcányiová A. Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus. Angiology. 1997;48(8):715–719.
   PubMed Web of Science ®Google Scholar
• Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31(1):42–48.
   PubMedGoogle Scholar
• Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis. 1981;34(6):261–269.
   PubMedGoogle Scholar
• Sigvant B, Wiberg-Hedman K, Bergqvist D, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 2007;45(6):1185–1191.
   PubMed Web of Science ®Google Scholar
• Vogt MT, Cauley JA, Kuller LH, et al. Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol. 1993;137(5):559–568.
   PubMed Web of Science ®Google Scholar
• Meijer WT, Hoes AW, Rutgers D, et al. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18(2):185–192.
   PubMed Web of Science ®Google Scholar
• Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20(2):384–392.
   PubMed Web of Science ®Google Scholar
• Vogt MT, Cauley JA, Kuller LH, et al. Functional status and mobility among elderly women with lower extremity arterial disease: the Study of Osteoporotic Fractures. J Am Geriatr Soc. 1994;42(9):923–929.
   PubMed Web of Science ®Google Scholar
• Vouyouka AG, Egorova NN, Salloum A, et al. Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial disease. J Vasc Surg. 2010;52(5):1196–1202.
   PubMed Web of Science ®Google Scholar
• McCoach CE, Armstrong EJ, Singh S, et al. Gender-related variation in the clinical presentation and outcomes of critical limb ischemia. Vasc Med. 2013;18(1):19–26.
   PubMed Web of Science ®Google Scholar
• Mangiafico RA, Russo E, Riccobene S, et al. Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women. J Bone Miner Metab. 2006;24(2):125–131.
   PubMed Web of Science ®Google Scholar
• Ness J, Aronow WS. Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia. Am J Cardiol. 2006;97(10):1427–1428.
   PubMed Web of Science ®Google Scholar
• Mya MM, Aronow WS. Increased prevalence of peripheral arterial disease in older men and women with subclinical hypothyroidism. J Gerontol A Biol Sci Med Sci. 2003;58(1):68–69.
   PubMed Web of Science ®Google Scholar
• Powell J, Zadeh JA, Carter G, et al. Raised serum thyrotrophin in women with peripheral arterial disease. Br J Surg. 1987;74(12):1139–1141.
   PubMed Web of Science ®Google Scholar
• Grenon SM, Cohen BE, Smolderen K, et al. Peripheral arterial disease, gender, and depression in the Heart and Soul Study. J Vasc Surg. 2014;60(2):396–403.
   PubMed Web of Science ®Google Scholar
• Van Den Bosch MA, Kemmeren JM, Tanis BC, et al. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost. 2003;1(3):439–444.
   PubMed Web of Science ®Google Scholar
• Westendorp IC, in’t Veld BA, Grobbee DE, et al. Hormone replacement therapy and peripheral arterial disease: the Rotterdam study. Arch Intern Med. 2000;160(16):2498–2502.
   PubMedGoogle Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Jama. 1998;280(7):605–613.
   PubMed Web of Science ®Google Scholar
• Timaran CH, Stevens SL, Grandas OH, et al. Influence of hormone replacement therapy on the outcome of iliac angioplasty and stenting. J Vasc Surg. 2001;33(2 Suppl):S85–S92.
   PubMed Web of Science ®Google Scholar
• Timaran CH, Stevens SL, Grandas OH, et al. Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting. J Vasc Surg. 2000;32(3):506–516;516–508.
   PubMed Web of Science ®Google Scholar
• Mazhari R, Hsia J. Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy? Vasc Health Risk Manag. 2005;1(2):111–117.
   PubMedGoogle Scholar
• Olin JW, Allie DE, Belkin M, et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). Circulation. 2010;122(24):2583–2618.
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47(6):1239–1312.
   PubMed Web of Science ®Google Scholar
• Nam SC, Han SH, Lim SH, et al. Factors affecting the validity of ankle-brachial index in the diagnosis of peripheral arterial obstructive disease. Angiology. 2010;61(4):392–396.
   PubMed Web of Science ®Google Scholar
• Li Q, Zeng H, Liu F, et al. High ankle-brachial index indicates cardiovascular and peripheral arterial disease in patients with type 2 diabetes. Angiology. 2015;66(10):918–924.
   PubMed Web of Science ®Google Scholar
• Hyun S, Forbang NI, Allison MA, et al. Ankle-brachial index, toe-brachial index, and cardiovascular mortality in persons with and without diabetes mellitus. J Vasc Surg. 2014;60(2):390–395.
   PubMedGoogle Scholar
• Aboyans V, Ho E, Denenberg JO, et al. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg. 2008;48(5):1197–1203.
   PubMed Web of Science ®Google Scholar
• Tehan PE, Bray A, Chuter VH. Non-invasive vascular assessment in the foot with diabetes: sensitivity and specificity of the ankle brachial index, toe brachial index and continuous wave Doppler for detecting peripheral arterial disease. J Diabetes Complications. 2016;30(1):155–160.
   PubMed Web of Science ®Google Scholar
• Ishida A, Miyagi M, Kinjo K, et al. Age- and sex-related effects on ankle-brachial index in a screened cohort of Japanese: the Okinawa Peripheral Arterial Disease Study (OPADS). Eur J Prev Cardiol. 2014;21(6):712–718.
   PubMed Web of Science ®Google Scholar
• Aboyans V, Criqui MH, McClelland RL, et al. Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg. 2007;45(2):319–327.
   PubMed Web of Science ®Google Scholar
• AhChong AK, Chiu KM, Wong M, et al. The influence of gender difference on the outcomes of infrainguinal bypass for critical limb ischaemia in Chinese patients. Eur J Vasc Endovasc Surg. 2002;23(2):134–139.
   PubMed Web of Science ®Google Scholar
• Ortmann J, Nüesch E, Cajöri G, et al. Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis. J Vasc Surg. 2011;54(6):1668–1678.
   PubMed Web of Science ®Google Scholar
• Barochiner J, Aparicio LS, Waisman GD. Challenges associated with peripheral arterial disease in women. Vasc Health Risk Manag. 2014;10:115–128.
   PubMedGoogle Scholar
• Welten GM, Schouten O, Hoeks SE, et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol. 2008;51(16):1588–1596.
   PubMed Web of Science ®Google Scholar
• Dreyer RP, Van Zitteren M, Beltrame JF, et al. Gender differences in health status and adverse outcomes among patients with peripheral arterial disease. J Am Heart Assoc. 2014;4(1):e000863.
   Web of Science ®Google Scholar
• Feinglass J, McDermott MM, Foroohar M, et al. Gender differences in interventional management of peripheral vascular disease: evidence from a blood flow laboratory population. Ann Vasc Surg. 1994;8(4):343–349.
   PubMedGoogle Scholar
• McDermott MM, Guralnik JM, Ferrucci L, et al. Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease. J Vasc Surg. 2007;46(1):87–93.
   PubMed Web of Science ®Google Scholar
• Li Y, Li Z, Chang G, et al. Effect of structured home-based exercise on walking ability in patients with peripheral arterial disease: a meta-analysis. Ann Vasc Surg. 2015;29(3):597–606.
   PubMed Web of Science ®Google Scholar
• Aherne T, McHugh S, Kheirelseid EA, et al. Comparing supervised exercise therapy to invasive measures in the management of symptomatic peripheral arterial disease. Surg Res Pract. 2015;2015:960402.
   PubMedGoogle Scholar
• Haas TL, Lloyd PG, Yang HT, et al. Exercise training and peripheral arterial disease. Compr Physiol. 2012;2(4):2933–3017.
   PubMed Web of Science ®Google Scholar
• Guirro EC, Guirro RR, Dibai-Filho AV, et al. Immediate effects of electrical stimulation, diathermy, and physical exercise on lower limb arterial blood flow in diabetic women with peripheral arterial disease: a randomized crossover trial. J Manipulative Physiol Ther. 2015;38(3):195–202.
   PubMed Web of Science ®Google Scholar
• Gommans LN, Scheltinga MR, Van Sambeek MR, et al. Gender differences following supervised exercise therapy in patients with intermittent claudication. J Vasc Surg. 2015;62(3):681–688.
   PubMed Web of Science ®Google Scholar
• Fakhry F, Rouwet EV, Den Hoed PT, et al. Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. Br J Surg. 2013;100(9):1164–1171.
   PubMed Web of Science ®Google Scholar
• Egorova N, Vouyouka AG, Quin J, et al. Analysis of gender-related differences in lower extremity peripheral arterial disease. J Vasc Surg. 2010;51(2):372–378.e371; discussion 378–379.
   PubMed Web of Science ®Google Scholar
• Domenick N, Saqib NU, Marone LK, et al. Impact of gender and age on outcomes of tibial artery endovascular interventions in critical limb ischemia. Ann Vasc Surg. 2012;26(7):937–945.
   PubMed Web of Science ®Google Scholar
• Green RM, Abbott WM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg. 2000;31(3):417–425.
   PubMed Web of Science ®Google Scholar
• Nguyen LL, Hevelone N, Rogers SO, et al. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation. 2009;119(1):123–130.
   PubMed Web of Science ®Google Scholar